Inc (OTCMKTS:NHLE) announced
the signing of a debt financing deal with Four twenty Investments Inc for $10
million. The company will use the funds to advance acquisition efforts in the
medical marijuana space. With favorable legislation, the demand for marijuana
for medical applications has increased several times.
for medical marijuana
The market for medical marijuana is
expected to reach $54.7 billion by the year 2023, growing at a CAGR of 34%.
Cannabis in marijuana plant offers
immense medical properties. Several pharmaceutical companies worldwide are
using marijuana for manufacturing medicine to treat various diseases. The
extracts of the marijuana plant are used to cure disorders and diseases caused
by diseases like Alzheimer’s disease and cancer. It is also widely used in
acceptance of marijuana for medical use
Several nations across the world are
using marijuana for the treatment of various chronic diseases. Therefore, it
stimulates the growth of cannabis going forward. However, stringent approval
procedures and government policies may restrict the growth of marijuana in the
of medical marijuana
Physicians are prescribing medical
marijuana to cure muscle spasms caused by chronic illness, weight loss, poor
appetite, multiple sclerosis, and nausea. It also helps to cure arthritis,
Parkinson’s disease, and neurological disorders. Therefore, improving medical
applications could spur the demand for medical marijuana.
Nhale will use its talent, leadership,
and resources to become a distinguished player and clinch a large pie of the
$54.7 billion medical marijuana market. Chief Executive Officer and President
of Nhale, Lance Williams, said the medical marijuana market offers excellent
opportunities for its team, who will collaborate with startups in the medical
Four Twenty Investments will provide
strategic investments and financing to support the companies engaged in medical
marijuana and cannabis. Nhale will tap Four Twenty Investments to pursue its
acquisitions in the legalized and recreational marijuana where it is legalized
to drive growth going forward.
Nhale is engaged in acquiring
companies that have promising potential and engaged in recreational and medical
marijuana space. It will promote industry awareness and use its talent and
leadership to help the companies in the cannabis space and reap rich rewards
for the shareholders.
Pharmaceutical Research Corp (OTCMKTS:OWCP)
and STENOCARE are into a new progressive deal. The two…
(OTCMKTS:PURA) has announced that it has finalized
the acquisition of a Germany company….
CV Sciences Inc. (OTCMKTS:CVSI) and Southeastern Grocers Inc. have announced a distribution partnership…
Kona Gold Solutions Inc (OTCMKTS:KGKG) has today
disclosed details about its new deal with AlaBev.This…
Published at Mon, 06 Jan 2020 13:15:00 +0000